Posted by admin on May 23rd, 2022

Avantor, Inc. (NYSE:AVTR – Get Rating) EVP Frederic Vanderhaegen sold 39,000 shares of the company’s stock in a transaction that occurred on Monday, May 23rd. The shares were sold at an average price of $31.61, for a total transaction of $1,232,790.00. Following the sale, the executive vice president now directly owns 126,764 shares of the company’s stock, valued at $4,007,010.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of NYSE:AVTR traded up $0.31 during trading hours on Monday, hitting $31.53. The company’s stock had a trading volume of 3,901,720 shares, compared to its average volume of 5,069,373. The company has a debt-to-equity ratio of 2.03, a current ratio of 1.80 and a quick ratio of 1.18. The firm’s fifty day moving average price is $32.02 and its 200 day moving average price is $35.66. Avantor, Inc. has a 52 week low of $28.64 and a 52 week high of $44.37. The company has a market capitalization of $19.24 billion, a price-to-earnings ratio of 35.43, a P/E/G ratio of 0.66 and a beta of 1.53.

Avantor (NYSE:AVTR – Get Rating) last announced its earnings results on Thursday, April 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.93 billion. Avantor had a return on equity of 32.17% and a net margin of 7.72%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.35 EPS. On average, equities research analysts predict that Avantor, Inc. will post 1.51 earnings per share for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in AVTR. Close Asset Management Ltd acquired a new stake in Avantor in the fourth quarter worth about $207,973,000. Dimensional Fund Advisors LP grew its position in Avantor by 21.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,842,564 shares of the company’s stock worth $75,361,000 after purchasing an additional 324,770 shares during the last quarter. Qube Research & Technologies Ltd increased its stake in Avantor by 35.5% during the 4th quarter. Qube Research & Technologies Ltd now owns 260,766 shares of the company’s stock valued at $10,989,000 after purchasing an additional 68,364 shares in the last quarter. Penserra Capital Management LLC raised its holdings in shares of Avantor by 97.3% in the third quarter. Penserra Capital Management LLC now owns 132,786 shares of the company’s stock worth $5,430,000 after buying an additional 65,495 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its stake in shares of Avantor by 4.0% during the fourth quarter. Principal Financial Group Inc. now owns 939,802 shares of the company’s stock worth $39,603,000 after buying an additional 35,802 shares during the period. 93.24% of the stock is owned by institutional investors and hedge funds.

AVTR has been the topic of several analyst reports. Wells Fargo & Company cut their price target on Avantor from $42.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, April 25th. TheStreet upgraded Avantor from a “c” rating to a “b-” rating in a report on Thursday. Raymond James decreased their target price on shares of Avantor from $43.00 to $40.00 and set an “outperform” rating on the stock in a research report on Monday, April 18th. Evercore ISI reduced their price objective on Avantor from $44.00 to $42.00 and set an “outperform” rating on the stock in a research note on Monday, April 4th. Finally, Barclays lifted their target price on Avantor from $41.00 to $44.00 and gave the stock an “overweight” rating in a report on Monday, February 7th. Two investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $43.13.

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.

Insider Buying: O’Reilly Automotive, Inc. (NASDAQ:ORLY) CFO Purchases 835 Shares of Stock

Head-To-Head Review: Alpha Teknova (TKNO) and Its Competitors